Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)

Kidney International Reports - United States
doi 10.1016/j.ekir.2017.02.019
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

Kidney International Reports
Nephrology
2017English

Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis

Nephro-Urology Monthly
Urology
2014English

Primary Focal Segmental Glomerulosclerosis: miRNAs and Targeted Therapies

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2016English

Urinary Soluble Urokinase Receptor Levels Are Elevated and Pathogenic in Patients With Primary Focal Segmental Glomerulosclerosis

BMC Medicine
Medicine
2014English

Focal Segmental Glomerulosclerosis

American Journal of Medicine
Medicine
1974English

Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Genetics of Focal Segmental Glomerulosclerosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2007English

NPHS2variation in Focal and Segmental Glomerulosclerosis

BMC Nephrology
Nephrology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy